# FDA 483 - Ronald B. Natale, MD - November 13, 2020

Source: https://www.keypedia.com/records/483/ronald-b-natale-md/d65181ca-0710-4739-af35-71206135a211

> FDA 483 for Ronald B. Natale, MD on November 13, 2020. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Ronald B. Natale, MD
- Inspection Date: 2020-11-13
- Product Type: drugs
- Office Name: Division of Pharmaceutical Quality Operations IV
- Summary: Ronald B. Natale, MD, Clinical Investigator in Los Angeles, CA, was inspected from November 5-13, 2020, for bioresearch monitoring. The inspection revealed a significant deficiency in maintaining adequate and accurate case histories. Specifically, the firm failed to transcribe critical data, including adverse events and concomitant medications, from source documents to electronic case report forms for submission to the study sponsor.

## Related Officers

- [Business Analyst/Provider Enrollment Specialist](https://www.keypedia.com/people/lakecha-n-lewis/39b6305d-2a9f-448b-9a14-e412b43c8522)

Company: https://www.keypedia.com/companies/ronald-b-natale-md/ca4e41a2-9fb5-4aa9-96f4-47b806d21ad3

Office: https://www.keypedia.com/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6